Platelet‐Based Nanotechnology Improves Cancer Immunotherapy
European Journal of Immunology · 2025-07 · 55 (7)
DOI: 10.1002/eji.70017 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Immunology, online erschienen am 24.07.2025. Verfasst von Yanlin Lv und 1 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, P. R. Chi…. Hauptthemen laut MEDLINE: Blood Platelets, Neoplasms, Immunotherapy, Nanotechnology. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 73 Literaturangaben.
Abstract (Originalsprache)
Cancer immunotherapy is a cornerstone of precision medicine, yet its efficacy is often hampered by the immunosuppressive and heterogeneous microenvironment of solid tumors. Biomimetic nanodelivery systems have emerged as promising tools to enhance therapeutic outcomes while minimizing off‐target effects. Among these, platelet (PLT)‐based systems offer unique advantages, including prolonged circulation, immune evasion, and tumor‐targeting capabilities. Of particular value is their ability to localize to sites of injury, which is a feature that nanocarriers cannot achieve. This review explores the multifaceted role of platelets in tumor development and metastasis, highlighting their bidirectional interactions with tumors. It further discusses the application of PLT‐based nanotechnology in cancer immunotherapy, emphasizing recent advancements in immune regulation, targeted therapy, and clinical translation. We also address the challenges and considerations in developing PLT‐based platforms, outlining future directions for their optimization in cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, P. R. China.
- School of Chemical Engineering, University of Chinese Academy of Sciences, Beijing, P. R. China.
ORCID-Profile: Guanghui Ma
Zitieren
APA
Lv, Y., & Ma, G. (2025). Platelet‐Based Nanotechnology Improves Cancer Immunotherapy. European Journal of Immunology, 55(7). https://doi.org/10.1002/eji.70017
Vancouver
Lv Y, Ma G. Platelet‐Based Nanotechnology Improves Cancer Immunotherapy. European Journal of Immunology. 2025;55(7). doi:10.1002/eji.70017
BibTeX
@article{Lv2025,
author = {Lv, Yanlin and Ma, Guanghui},
title = {Platelet‐Based Nanotechnology Improves Cancer Immunotherapy},
journal = {European Journal of Immunology},
year = {2025},
volume = {55},
number = {7},
doi = {10.1002/eji.70017}
}
EUVIMED